Brian Metcalf, Ph.D.
Executive Vice President, Chemistry
Well known in the biotechnology industry for his expertise in drug discovery and medicinal chemistry, Dr. Brian W. Metcalf, Ph.D., most recently served as senior advisor and acting chief scientific officer of Global Blood Therapeutics Inc. Previously, he was the head of drug discovery at Incyte Corp. and chief scientific officer of Kosan Biosciences Inc. Earlier in his career, Dr. Metcalf served in a number of executive management roles with SmithKline Beecham, including as its senior vice president of discovery chemistry and platform technologies, and he spent a decade with the Merrell Research Center, working from its Strasbourg, France and Cincinnati, Ohio locations. He is the inventor of the anti-epileptic drug Vigabatrin and has numerous patents and publications in the drug discovery arena. He has been Member of Scientific Advisory Board at BriaCell Therapeutics Corp. since May 31, 2017. Dr. Metcalf served as a Director of Argonaut Technologies Inc. since May 2000. Dr. Metcalf is well known in the industry for his expertise in drug discovery and medicinal chemistry. Dr. Metcalf has a B.S. and a Ph.D. in Organic Chemistry from the University of Western Australia and Postdoctoral Studies at University College London and Stanford University.